Endovascular Specialist Competencies for Chronic Limb-Threatening Ischemia: What's in Your Toolbox?
作者信息
Aronow Herbert D, Rosenfield Kenneth
机构信息
Lifespan Cardiovascular Institute, Providence, Rhode Island.
Division of Cardiology, Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island.
出版信息
J Soc Cardiovasc Angiogr Interv. 2022 Apr 25;1(3):100018. doi: 10.1016/j.jscai.2022.100018. eCollection 2022 May-Jun.
Abstract
摘要
相似文献
1
Endovascular Specialist Competencies for Chronic Limb-Threatening Ischemia: What's in Your Toolbox?慢性肢体威胁性缺血的血管内介入专家能力：你的工具包里有什么？
J Soc Cardiovasc Angiogr Interv. 2022 Apr 25;1(3):100018. doi: 10.1016/j.jscai.2022.100018. eCollection 2022 May-Jun.
2
Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.股浅动脉腔内治疗联合腘动脉至远端旁路移植术的有效性：慢性肢体威胁性缺血手术开放旁路移植术的范式转变。
Vascular. 2021 Dec;29(6):905-912. doi: 10.1177/1708538120981224. Epub 2020 Dec 21.
3
Prediction of Wound Recurrence in Patients With Chronic Limb-Threatening Ischemia Undergoing Endovascular Treatment.慢性肢体严重缺血患者血管内治疗后创面复发的预测。
J Endovasc Ther. 2023 Oct;30(5):703-710. doi: 10.1177/15266028221098702. Epub 2022 Jun 16.
4
A scoping review of female sex-related outcomes after endovascular intervention for lifestyle-limiting claudication and chronic limb-threatening ischemia.腔内介入治疗生活受限性跛行和慢性肢体威胁性缺血后与女性性别相关结局的范围综述。
Semin Vasc Surg. 2023 Dec;36(4):541-549. doi: 10.1053/j.semvascsurg.2023.10.001. Epub 2023 Oct 14.
5
A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial.对于需要进行 below-the-knee（小腿）、伴或不伴额外更近端 below-inguinal（腹股沟下）血运重建以恢复肢体灌注的慢性肢体威胁性缺血患者，静脉旁路优先与最佳血管内治疗优先再血管化策略的比较（BASIL-2）：一项开放标签、随机、多中心、3 期试验。
Lancet. 2023 May 27;401(10390):1798-1809. doi: 10.1016/S0140-6736(23)00462-2. Epub 2023 Apr 25.
6
Secondary interventions following open vs endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial.BEST-CLI试验中针对慢性肢体威胁性缺血进行开放与血管内血运重建后的二级干预措施。
J Vasc Surg. 2024 Jun;79(6):1428-1437.e4. doi: 10.1016/j.jvs.2024.02.005. Epub 2024 Feb 17.
7
Outcomes of open and endovascular interventions in patients with chronic limb threatening ischemia.慢性肢体威胁性缺血患者开放手术与血管腔内介入治疗的疗效
Vascular. 2021 Oct;29(5):693-703. doi: 10.1177/1708538120971972. Epub 2020 Nov 15.
8
Severe inframalleolar disease is an independent predictor of adverse limb outcomes after endovascular revascularization in chronic limb-threatening ischemia.严重的内踝下疾病是慢性肢体威胁性缺血血管腔内血运重建术后肢体不良结局的独立预测因素。
J Vasc Surg. 2023 Mar;77(3):858-863. doi: 10.1016/j.jvs.2022.10.042. Epub 2022 Nov 1.
9
Patient and limb outcomes 10 years after endovascular revascularization of the superficial femoral artery for peripheral artery disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) study.患者和肢体结局 10 年后外周动脉疾病的股浅动脉腔内血管重建：波士顿股动脉腔内血管重建结局（Boston FAROUT）研究。
Vasc Med. 2023 Aug;28(4):290-298. doi: 10.1177/1358863X231174052. Epub 2023 May 21.
10
Chronic Limb-Threatening Ischemia in Patients with Type 2 Diabetes: Revascularization Index as a Predictor for Primary Endovascular Intervention Outcome.2 型糖尿病患者的慢性肢体威胁性缺血：再血管化指数作为主要血管内介入治疗结局的预测指标。
Vasc Health Risk Manag. 2023 Jul 31;19:495-504. doi: 10.2147/VHRM.S394521. eCollection 2023.
本文引用的文献
1
Impact of Interdisciplinary System-Wide Limb Salvage Advisory Council on Lower Extremity Major Amputation.跨学科全系统肢体挽救咨询委员会对下肢大截肢的影响
Circ Cardiovasc Interv. 2022 Jan;15(1):e011306. doi: 10.1161/CIRCINTERVENTIONS.121.011306. Epub 2021 Dec 21.
2
2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions).2021年美国心脏病学会/美国心脏协会/血管医学学会/美国内科医师学会血管医学高级培训声明（2004年美国心脏病学会/美国内科医师学会/心血管造影和介入学会/血管医学和介入放射学会/血管外科学会血管医学和基于导管的外周血管介入临床能力声明的修订版）
Vasc Med. 2021 Feb;26(1):91-112. doi: 10.1177/1358863X20987551. Epub 2021 Jan 15.
3
In the Fundamentals of Endovascular and Vascular Surgery model motion metrics reliably differentiate competency.在血管外科学和血管外科学基础模型运动指标中，可靠地区分能力。
J Vasc Surg. 2020 Dec;72(6):2161-2165. doi: 10.1016/j.jvs.2020.02.047. Epub 2020 Apr 8.
4
Vascular Teams in Peripheral Vascular Disease.外周血管疾病中的血管团队。
J Am Coll Cardiol. 2019 May 21;73(19):2477-2486. doi: 10.1016/j.jacc.2019.03.463.
5
Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial.严重肢体缺血患者最佳血管内治疗与最佳手术治疗对比试验（BEST-CLI）的设计与原理
J Am Heart Assoc. 2016 Jul 8;5(7):e003219. doi: 10.1161/JAHA.116.003219.
6
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.严重下肢缺血的搭桥术与血管成形术对比研究（BASIL）：多中心随机对照试验
Lancet. 2005 Dec 3;366(9501):1925-34. doi: 10.1016/S0140-6736(05)67704-5.
7
ACC/ACP/SCAI/SVMB/SVS clinical competence statement on vascular medicine and catheter-based peripheral vascular interventions: a report of the American College of Cardiology/American Heart Association/American College of Physician Task Force on Clinical Competence (ACC/ACP/SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on peripheral vascular disease).美国心脏病学会/美国内科医师学会/心血管造影和介入学会/血管医学和生物学学会/血管外科学会关于血管医学和基于导管的外周血管介入的临床能力声明：美国心脏病学会/美国心脏协会/美国内科医师学会临床能力特别工作组报告（美国心脏病学会/美国内科医师学会/心血管造影和介入学会/血管医学和生物学学会/血管外科学会编写委员会制定外周血管疾病临床能力声明）
J Am Coll Cardiol. 2004 Aug 18;44(4):941-57. doi: 10.1016/j.jacc.2003.10.012.
Zotero 插件